Laronidase ERT [clinicaltrials_resource:315591f7dfc707f02fa5f5356aecf56d]
intervention [clinicaltrials_vocabulary:intervention]
Laronidase ERT [clinicaltrials_resource:315591f7dfc707f02fa5f5356aecf56d]
Bio2RDF identifier
315591f7dfc707f02fa5f5356aecf56d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:315591f7dfc707f02fa5f5356aecf56d
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Laronidase ERT will be administered 10-12 weeks prior to HSCT, and 8 weeks following.
intervention name [clinicaltrials_vocabulary:intervention-name]
Laronidase ERT
other name [clinicaltrials_vocabulary:other-name]
Aldurazyme®
identifier
clinicaltrials_resource:315591f7dfc707f02fa5f5356aecf56d
title
Laronidase ERT
@en
type
label
Laronidase ERT [clinicaltrials_resource:315591f7dfc707f02fa5f5356aecf56d]
@en